StockWatch
·
Pharmaceuticals
Business Update20 Nov 2026, 09:11 am

Wanbury API Facility Clears South Korea MFDS cGMP Inspection

AI Summary

Wanbury Limited's API manufacturing facility in Tanuku, Andhra Pradesh, has successfully completed a three-day cGMP inspection by South Korea's Ministry of Food and Drug Safety (MFDS) with zero observations. This follows a similar successful inspection at the company's Patalganga facility in April 2026. These achievements underscore Wanbury's commitment to quality, regulatory compliance, and operational excellence, with the company continuing to focus on enhancing its quality systems and manufacturing standards.

Key Highlights

  • Tanuku API facility passed South Korea MFDS cGMP inspection.
  • Inspection resulted in zero observations, highlighting strong compliance.
  • This follows a similar successful inspection at the Patalganga facility.
  • Demonstrates Wanbury's commitment to international quality standards.